Multifactor Dimensionality Reduction Reveals Gene-gene Interactions Associated with Multiple Sclerosis Susceptibility in African Americans

Overview

Journal Genes Immun

Date 2006 Apr 21

PMID 16625214

Citations 20

Authors

D Brassat

A A Motsinger

S J Caillier

H A Erlich

K Walker

L L Steiner

B A C Cree

L F Barcellos

M A Pericak-Vance

S Schmidt

S Gregory

S L Hauser

J L Haines

J R Oksenberg

M D Ritchie

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is a common disease of the central nervous system characterized by inflammation, myelin loss, gliosis, varying degrees of axonal pathology, and progressive neurological dysfunction. Multiple sclerosis exhibits many of the characteristics that distinguish complex genetic disorders including polygenic inheritance and environmental exposure risks. Here, we used a highly efficient multilocus genotyping assay representing variation in 34 genes associated with inflammatory pathways to explore gene-gene interactions and disease susceptibility in a well-characterized African-American case-control MS data set. We applied the multifactor dimensionality reduction (MDR) test to detect epistasis, and identified single-IL4R(Q576R)- and three-IL4R(Q576R), IL5RA(-80), CD14(-260)- locus association models that predict MS risk with 75-76% accuracy (P<0.01). These results demonstrate the importance of exploring both main effects and gene-gene interactions in the study of complex diseases.

Citing Articles

A Framework for Efficient N-Way Interaction Testing in Case/Control Studies With Categorical Data.

Aristodimou A, Antoniades A, Dardiotis E, Loizidou E, Spyrou G, Votsi C IEEE Open J Eng Med Biol. 2022; 2:256-262.

PMID: 35402966 PMC: 8901013. DOI: 10.1109/OJEMB.2021.3100416.

Bruton's Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures.

Ringheim G, Wampole M, Oberoi K Front Immunol. 2021; 12:662223.

PMID: 34803999 PMC: 8595937. DOI: 10.3389/fimmu.2021.662223.

Association of , and Genes Polymorphisms With the Calcium Urolithiasis Development in Russian Population.

Litvinova M, Khafizov K, Korchagin V, Speranskaya A, Asanov A, Matsvay A Front Genet. 2021; 12:621049.

PMID: 34054913 PMC: 8153711. DOI: 10.3389/fgene.2021.621049.

Mining Complex Genetic Patterns Conferring Multiple Sclerosis Risk.

Briggs F, Sept C Int J Environ Res Public Health. 2021; 18(5).

PMID: 33802599 PMC: 7967327. DOI: 10.3390/ijerph18052518.

Network graph analysis of gene-gene interactions in genome-wide association study data.

Lee S, Kwon M, Park T Genomics Inform. 2013; 10(4):256-62.

PMID: 23346039 PMC: 3543927. DOI: 10.5808/GI.2012.10.4.256.

References

Nelms K, Keegan A, Zamorano J, Ryan J, Paul W . The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999; 17:701-38. DOI: 10.1146/annurev.immunol.17.1.701. View

Wallin M, Page W, Kurtzke J . Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol. 2004; 55(1):65-71. DOI: 10.1002/ana.10788. View

Lincoln M, Montpetit A, Cader M, Saarela J, Dyment D, Tiislar M . A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005; 37(10):1108-12. DOI: 10.1038/ng1647. View

Sawcer S, Ban M, Maranian M, Yeo T, Compston A, Kirby A . A high-density screen for linkage in multiple sclerosis. Am J Hum Genet. 2005; 77(3):454-67. PMC: 1226210. DOI: 10.1086/444547. View

Sandford A, Chagani T, Zhu S, Weir T, Bai T, Spinelli J . Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol. 2000; 106(1 Pt 1):135-40. DOI: 10.1067/mai.2000.107926. View

Ritchie M, Motsinger A . Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics. 2005; 6(8):823-34. DOI: 10.2217/14622416.6.8.823. View

Traherne J, Barcellos L, Sawcer S, Compston A, Ramsay P, Hauser S . Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet. 2005; 15(1):155-61. DOI: 10.1093/hmg/ddi436. View

Mirel D, Valdes A, Lazzeroni L, Reynolds R, Erlich H, Noble J . Association of IL4R haplotypes with type 1 diabetes. Diabetes. 2002; 51(11):3336-41. DOI: 10.2337/diabetes.51.11.3336. View

Plumb J, Armstrong M, Duddy M, Mirakhur M, McQuaid S . CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions. Mult Scler. 2003; 9(2):142-7. DOI: 10.1191/1352458503ms890oa. View

10.

Oksenberg J, Barcellos L, Cree B, Baranzini S, Bugawan T, Khan O . Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet. 2003; 74(1):160-7. PMC: 1181903. DOI: 10.1086/380997. View

11.

Suppiah V, Goris A, Alloza I, Heggarty S, Dubois B, Carton H . Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: a study in Spanish-Basque, Northern Irish and Belgian populations. Int J Immunogenet. 2005; 32(6):383-8. DOI: 10.1111/j.1744-313X.2005.00542.x. View

12.

Cree B, Al-Sabbagh A, Bennett R, Goodin D . Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol. 2005; 62(11):1681-3. DOI: 10.1001/archneur.62.11.1681. View

13.

Peduzzi P, Concato J, Kemper E, Holford T, Feinstein A . A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996; 49(12):1373-9. DOI: 10.1016/s0895-4356(96)00236-3. View

14.

Huang Y, Xiao B, Ozenci V, Kouwenhoven M, Teleshova N, Fredrikson S . Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J Neuroimmunol. 1999; 99(1):82-90. DOI: 10.1016/s0165-5728(99)00106-x. View

15.

Oksenberg J, Barcellos L . Multiple sclerosis genetics: leaving no stone unturned. Genes Immun. 2005; 6(5):375-87. DOI: 10.1038/sj.gene.6364237. View

16.

Reich D, Patterson N, De Jager P, McDonald G, Waliszewska A, Tandon A . A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet. 2005; 37(10):1113-8. DOI: 10.1038/ng1646. View

17.

McDonald W, Compston A, Edan G, Goodkin D, Hartung H, Lublin F . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1):121-7. DOI: 10.1002/ana.1032. View

18.

Cree B, Khan O, Bourdette D, Goodin D, Cohen J, Marrie R . Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2004; 63(11):2039-45. DOI: 10.1212/01.wnl.0000145762.60562.5d. View

19.

Moore J, Williams S . New strategies for identifying gene-gene interactions in hypertension. Ann Med. 2002; 34(2):88-95. DOI: 10.1080/07853890252953473. View

20.

Hershey G, Friedrich M, Esswein L, Thomas M, Chatila T . The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med. 1997; 337(24):1720-5. DOI: 10.1056/NEJM199712113372403. View